Physician
Corporacion De Salud Asegurada Por Nuestra Organizacion Solidaria INC.
Corporacion De Salud Asegurada Por Nuestra Organizacion Solidaria INC. was paid $389K by Medicaid between Jan 2018 and Dec 2024, across 143 billing codes. Its largest line is 90471, Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine — 24% of everything it billed.
33Billing provider infoCORPORACION DE SALUD ASEGURADA POR NUESTRA ORGANIZACION SOLIDARIA INC.
CAGUAS, PR 00725
CAGUAS, PR 00725
33aNPI1548321029assigned 12/12/2006
33bProvider typePublic Health & General Preventive Medicine Physician
28Total paid$389K
24GClaims268,789
24DCodes billed143
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Public Health & General Preventive Medicine Physician providers in Puerto Rico
Rank by total paid#2 of 8
Median peer was paid$215.00
This provider vs. median1,808×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,092 | $7K | |
| 2019 | 38,222 | $6K | |
| 2020 | 24,791 | $9K | |
| 2021 | 33,240 | $74K | |
| 2022 | 32,887 | $82K | |
| 2023 | 47,662 | $94K | |
| 2024incomplete | 79,895 | $117K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 24% | 9,286 | 7,379 | $94K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 47,340 | 37,648 | $73K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 17% | 4,548 | 3,795 | $65K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 7.3% | 8,835 | 8,046 | $28K |
| 0001A | 4.4% | 533 | 486 | $17K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.2% | 5,223 | 3,987 | $13K |
| 0002A | 2.7% | 368 | 355 | $10K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.5% | 2,685 | 2,283 | $10K |
| 99442 | 2.5% | 2,874 | 2,476 | $10K | |
| 90461 | 2.3% | 1,707 | 1,530 | $9K | |
| 0003A | 2.2% | 221 | 220 | $9K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 2.1% | 464 | 428 | $8K |
131 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 9,120 | $8K |
| 96160 | 1.8% | 895 | $7K | |
| 99441 | 1.6% | 7,563 | $6K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 110 | $2K |
| 90670 | <1% | 1,695 | $2K | |
| 90688 | <1% | 1,486 | $2K | |
| 90474 | <1% | 383 | $1K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 839 | $1K |
| 0031A | <1% | 30 | $1K | |
| 90651 | <1% | 2,170 | $1K | |
| 88141 | <1% | 138 | $1K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,628 | $887.71 |
| 97802 | <1% | 132 | $871.90 | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 95 | $732.96 |
| 90697 | <1% | 605 | $732.90 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 2,248 | $686.66 |
| 90620 | <1% | 989 | $681.71 | |
| 90734 | <1% | 1,487 | $632.81 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 586 | $598.30 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 300 | $469.20 |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $402.24 |
| 97803 | <1% | 73 | $326.48 | |
| 90680 | <1% | 348 | $300.00 | |
| 90674 | <1% | 136 | $260.80 | |
| 80305 | <1% | 2,131 | $225.58 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 393 | $163.87 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 153 | $140.36 |
| 90681 | <1% | 68 | $140.00 | |
| 90694 | <1% | 453 | $138.11 | |
| G2010 | Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment | <1% | 35 | $115.18 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 390 | $100.42 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 460 | $96.51 |
| 99421 | <1% | 796 | $89.76 | |
| 90687 | <1% | 249 | $87.65 | |
| 90746 | <1% | 14 | $71.00 | |
| 99050 | <1% | 1,389 | $66.00 | |
| 90686 | <1% | 1,232 | $60.13 | |
| 96127 | <1% | 1,351 | $51.75 | |
| 90715 | <1% | 847 | $47.50 | |
| 90633 | <1% | 1,615 | $46.00 | |
| 90700 | <1% | 515 | $27.63 | |
| 80354 | <1% | 135 | $13.01 | |
| 90707 | <1% | 1,085 | $12.02 | |
| 90658 | <1% | 115 | $12.00 | |
| 90716 | <1% | 1,245 | $0.04 | |
| 90696 | <1% | 341 | $0.03 | |
| 99406 | <1% | 769 | $0.03 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,460 | $0.01 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,437 | $0.01 |
| 3008F | <1% | 31,317 | $0.01 | |
| 1000F | <1% | 17,619 | $0.01 | |
| 3077F | 0% | 3,487 | $0.00 | |
| 4004F | 0% | 1,527 | $0.00 | |
| 3015F | 0% | 156 | $0.00 | |
| 3078F | 0% | 15,055 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 515 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 355 | $0.00 |
| 3725F | 0% | 4,011 | $0.00 | |
| 1159F | 0% | 644 | $0.00 | |
| 99408 | 0% | 3,424 | $0.00 | |
| 90648 | 0% | 30 | $0.00 | |
| 1160F | 0% | 618 | $0.00 | |
| 0518F | 0% | 12 | $0.00 | |
| 4013F | 0% | 781 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 210 | $0.00 |
| 4551F | 0% | 511 | $0.00 | |
| 99401 | 0% | 94 | $0.00 | |
| 91300 | 0% | 607 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 15 | $0.00 |
| 90710 | 0% | 45 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 133 | $0.00 |
| 99001 | 0% | 26 | $0.00 | |
| 90649 | 0% | 61 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 64 | $0.00 |
| 90713 | 0% | 15 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 116 | $0.00 |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 0% | 190 | $0.00 |
| 99173 | 0% | 122 | $0.00 | |
| 90756 | 0% | 39 | $0.00 | |
| 90672 | 0% | 19 | $0.00 | |
| 1033F | 0% | 13 | $0.00 | |
| 3050F | 0% | 61 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 24 | $0.00 |
| 90621 | 0% | 29 | $0.00 | |
| 90837 | Psychotherapy session, about an hour | 0% | 33 | $0.00 |
| 3079F | 0% | 4,337 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 19 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 396 | $0.00 |
| 4000F | 0% | 826 | $0.00 | |
| 1111F | 0% | 3,456 | $0.00 | |
| 3080F | 0% | 552 | $0.00 | |
| 99368 | 0% | 310 | $0.00 | |
| 1036F | 0% | 12,473 | $0.00 | |
| 3074F | 0% | 14,040 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 357 | $0.00 |
| 1034F | 0% | 1,978 | $0.00 | |
| 90698 | 0% | 151 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 2,062 | $0.00 |
| 1170F | 0% | 73 | $0.00 | |
| 3017F | 0% | 541 | $0.00 | |
| 1031F | 0% | 355 | $0.00 | |
| 3292F | 0% | 785 | $0.00 | |
| 3075F | 0% | 2,496 | $0.00 | |
| 1157F | 0% | 19 | $0.00 | |
| 90677 | 0% | 144 | $0.00 | |
| 3072F | 0% | 15 | $0.00 | |
| 3048F | 0% | 928 | $0.00 | |
| 88174 | 0% | 142 | $0.00 | |
| 90723 | 0% | 13 | $0.00 | |
| 1126F | 0% | 141 | $0.00 | |
| 3044F | 0% | 1,502 | $0.00 | |
| 3061F | 0% | 169 | $0.00 | |
| 80050 | General health panel | 0% | 66 | $0.00 |
| 2001F | 0% | 30 | $0.00 | |
| 90647 | 0% | 292 | $0.00 | |
| 3049F | 0% | 268 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 40 | $0.00 |
| 1030F | 0% | 362 | $0.00 | |
| 90619 | 0% | 110 | $0.00 | |
| 4086F | 0% | 28 | $0.00 | |
| 91301 | 0% | 32 | $0.00 | |
| H0001 | Alcohol and/or drug assessment | 0% | 77 | $0.00 |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 23 | $0.00 |
| 1123F | 0% | 53 | $0.00 | |
| 10004 | 0% | 54 | $0.00 | |
| 3014F | 0% | 30 | $0.00 | |
| 99443 | 0% | 23 | $0.00 | |
| 2000F | 0% | 19 | $0.00 | |
| 1125F | 0% | 147 | $0.00 | |
| 4010F | 0% | 26 | $0.00 | |
| 1035F | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMONTIJO, CESAR (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Corporacion De Salud Asegurada Por Nuestra Organizacion Solidaria, INC | Caguas, PR | $247K |
| Corporacion De Salud Asegurada Por Nuestra Organizacion Solidaria, INC | Caguas, PR | $105K |
| Corporacion De Salud Asegurada Por Nuestra Organizacion Solidaria, INC | Caguas, PR | $9K |
| Corporacion De Salud Asegurada Por Nuestra Organizacion Solidaria, INC | Caguas, PR | $29.26 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.